Pieris napi chromosome 3, ilPieNapi1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Lepidoptera; Glossata; Ditrysia; Papilionoidea; Pieridae; Pierinae; Pieris.
REFSEQ INFORMATION: The reference sequence is identical to\nFR997697.1.\nAssembly name: ilPieNapi1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/01/30. The original whole-genome shotgun project has the\naccession CAJQFT000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Pieris napi Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
acetylcholine receptor subunit alpha-like, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
acetylcholine receptor subunit alpha-like isoform X1
acetylcholine receptor subunit alpha-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 248 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
acetylcholine receptor subunit alpha-like isoform X2
NKAP family protein CG6066, transcript variant X2
NKAP family protein CG6066, transcript variant X1
GA-binding protein subunit beta-2, transcript variant X3
GA-binding protein subunit beta-2, transcript variant X6
GA-binding protein subunit beta-2, transcript variant X4
GA-binding protein subunit beta-2, transcript variant X7
GA-binding protein subunit beta-2, transcript variant X1
GA-binding protein subunit beta-2, transcript variant X5
GA-binding protein subunit beta-2, transcript variant X2
GA-binding protein subunit beta-2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
coiled-coil domain-containing protein 63-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 1, transcript variant X2
zinc finger protein 1, transcript variant X1
zinc finger protein 1, transcript variant X4
zinc finger protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transfer RNA valine (anticodon AAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon CCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
cytoplasmic dynein 1 intermediate chain, transcript variant X2
cytoplasmic dynein 1 intermediate chain, transcript variant X1
cytoplasmic dynein 1 intermediate chain, transcript variant X5
cytoplasmic dynein 1 intermediate chain, transcript variant X7
cytoplasmic dynein 1 intermediate chain, transcript variant X15
cytoplasmic dynein 1 intermediate chain, transcript variant X3
cytoplasmic dynein 1 intermediate chain, transcript variant X8
cytoplasmic dynein 1 intermediate chain, transcript variant X11
cytoplasmic dynein 1 intermediate chain, transcript variant X4
cytoplasmic dynein 1 intermediate chain, transcript variant X9
cytoplasmic dynein 1 intermediate chain, transcript variant X12
cytoplasmic dynein 1 intermediate chain, transcript variant X19
cytoplasmic dynein 1 intermediate chain, transcript variant X6
cytoplasmic dynein 1 intermediate chain, transcript variant X14
cytoplasmic dynein 1 intermediate chain, transcript variant X17
cytoplasmic dynein 1 intermediate chain, transcript variant X10
cytoplasmic dynein 1 intermediate chain, transcript variant X16
cytoplasmic dynein 1 intermediate chain, transcript variant X18
cytoplasmic dynein 1 intermediate chain, transcript variant X21
cytoplasmic dynein 1 intermediate chain, transcript variant X13
cytoplasmic dynein 1 intermediate chain, transcript variant X20
cytoplasmic dynein 1 intermediate chain isoform X1
cytoplasmic dynein 1 intermediate chain isoform X4
cytoplasmic dynein 1 intermediate chain isoform X6
cytoplasmic dynein 1 intermediate chain isoform X14
cytoplasmic dynein 1 intermediate chain isoform X2
cytoplasmic dynein 1 intermediate chain isoform X7
cytoplasmic dynein 1 intermediate chain isoform X10
cytoplasmic dynein 1 intermediate chain isoform X3
cytoplasmic dynein 1 intermediate chain isoform X8
cytoplasmic dynein 1 intermediate chain isoform X11
cytoplasmic dynein 1 intermediate chain isoform X18
cytoplasmic dynein 1 intermediate chain isoform X5
cytoplasmic dynein 1 intermediate chain isoform X13
cytoplasmic dynein 1 intermediate chain isoform X16
cytoplasmic dynein 1 intermediate chain isoform X9
cytoplasmic dynein 1 intermediate chain isoform X15
cytoplasmic dynein 1 intermediate chain isoform X17
cytoplasmic dynein 1 intermediate chain isoform X20
cytoplasmic dynein 1 intermediate chain isoform X12
cytoplasmic dynein 1 intermediate chain isoform X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 225-like, transcript variant X1
zinc finger protein 225-like, transcript variant X2
moesin/ezrin/radixin homolog 1, transcript variant X2
moesin/ezrin/radixin homolog 1, transcript variant X3
moesin/ezrin/radixin homolog 1, transcript variant X1
moesin/ezrin/radixin homolog 1 isoform X2
moesin/ezrin/radixin homolog 1 isoform X3
moesin/ezrin/radixin homolog 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 167 samples with support for all annotated introns
phospholipase B1, membrane-associated-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
bifunctional arginine demethylase and lysyl-hydroxylase JMJD6-A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized protein LOC125063198 isoform X1
bifunctional arginine demethylase and lysyl-hydroxylase JMJD6-A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
bifunctional arginine demethylase and lysyl-hydroxylase JMJD6-A isoform X2
V-type proton ATPase 116 kDa subunit a 1-like, transcript variant X2
V-type proton ATPase 116 kDa subunit a 1-like, transcript variant X1
V-type proton ATPase 116 kDa subunit a 1-like, transcript variant X4
V-type proton ATPase 116 kDa subunit a 1-like, transcript variant X3
V-type proton ATPase 116 kDa subunit a 1-like isoform X2
V-type proton ATPase 116 kDa subunit a 1-like isoform X1
V-type proton ATPase 116 kDa subunit a 1-like isoform X4
V-type proton ATPase 116 kDa subunit a 1-like isoform X3
uncharacterized LOC125063192, transcript variant X3
uncharacterized LOC125063192, transcript variant X2
uncharacterized LOC125063192, transcript variant X1
uncharacterized protein LOC125063192 isoform X3
uncharacterized protein LOC125063192 isoform X2
uncharacterized protein LOC125063192 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
putative uncharacterized protein DDB_G0290521
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
cell wall protein DAN4-like, transcript variant X2
cell wall protein DAN4-like, transcript variant X1
multiple epidermal growth factor-like domains protein 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 119 samples with support for all annotated introns
leucine-rich repeat-containing protein 40
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 42% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC125063741, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 136 samples with support for all annotated introns
uncharacterized protein LOC125063741 isoform X1
uncharacterized LOC125063741, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 106 samples with support for all annotated introns
uncharacterized protein LOC125063741 isoform X2
uncharacterized LOC125063741, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized LOC125063741, transcript variant X3
uncharacterized protein LOC125063741 isoform X3
U3 small nucleolar RNA-associated protein 18 homolog
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic, transcript variant X2
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic isoform X2
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic isoform X1
methionyl-tRNA formyltransferase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 144 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 132 samples with support for all annotated introns
beta-1,4-mannosyltransferase egh-like, transcript variant X1
beta-1,4-mannosyltransferase egh-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
beta-1,4-mannosyltransferase egh-like isoform X1
beta-1,4-mannosyltransferase egh-like isoform X2
disintegrin and metalloproteinase domain-containing protein 10, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 10, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 10 isoform X2
disintegrin and metalloproteinase domain-containing protein 10 isoform X1
peptidyl-prolyl cis-trans isomerase F, mitochondrial-like
uncharacterized LOC125063791, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
uncharacterized LOC125063791, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
synaptic vesicle glycoprotein 2B-like, transcript variant X1
synaptic vesicle glycoprotein 2B-like isoform X1
synaptic vesicle glycoprotein 2B-like, transcript variant X3
synaptic vesicle glycoprotein 2B-like isoform X3
synaptic vesicle glycoprotein 2B-like, transcript variant X2
synaptic vesicle glycoprotein 2B-like isoform X2
thiamin pyrophosphokinase 1, transcript variant X2
thiamin pyrophosphokinase 1, transcript variant X1
V-type proton ATPase 116 kDa subunit a 1
tetratricopeptide repeat protein 21B-like, transcript variant X1
tetratricopeptide repeat protein 21B-like, transcript variant X2
tetratricopeptide repeat protein 21B-like
uncharacterized LOC125063606, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC125063606, transcript variant X10
uncharacterized LOC125063606, transcript variant X11
uncharacterized LOC125063606, transcript variant X12
uncharacterized LOC125063606, transcript variant X1
uncharacterized LOC125063606, transcript variant X7
uncharacterized LOC125063606, transcript variant X5
uncharacterized LOC125063606, transcript variant X6
uncharacterized LOC125063606, transcript variant X4
uncharacterized LOC125063606, transcript variant X3
uncharacterized LOC125063606, transcript variant X2
uncharacterized protein LOC125063606 isoform X1
uncharacterized protein LOC125063606 isoform X4
uncharacterized protein LOC125063606 isoform X2
uncharacterized protein LOC125063606 isoform X3
uncharacterized protein LOC125063606 isoform X7
uncharacterized protein LOC125063606 isoform X8
uncharacterized protein LOC125063606 isoform X9
uncharacterized protein LOC125063606 isoform X6
uncharacterized LOC125063606, transcript variant X8
uncharacterized protein LOC125063606 isoform X5
uncharacterized LOC125048489, transcript variant X2
uncharacterized LOC125048489, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
acyl-CoA Delta(11) desaturase-like, transcript variant X1
acyl-CoA Delta(11) desaturase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein C15orf61 homolog, transcript variant X1
uncharacterized protein C15orf61 isoform X1
uncharacterized protein C15orf61 homolog, transcript variant X2
uncharacterized protein C15orf61 homolog isoform X2
patched domain-containing protein 3-like
nuclear factor NF-kappa-B p110 subunit, transcript variant X2
nuclear factor NF-kappa-B p110 subunit, transcript variant X1
nuclear factor NF-kappa-B p110 subunit isoform X1
nuclear factor NF-kappa-B p110 subunit isoform X2
bifunctional purine biosynthesis protein ATIC
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
RYamide receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RYamide receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine-rich melanocyte differentiation-associated protein-like, transcript variant X2
leucine-rich melanocyte differentiation-associated protein-like isoform X2
leucine-rich melanocyte differentiation-associated protein-like, transcript variant X1
leucine-rich melanocyte differentiation-associated protein-like isoform X1
SH3 domain-containing kinase-binding protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 107 samples with support for all annotated introns
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial-like
Fanconi anemia group M protein, transcript variant X1
Fanconi anemia group M protein, transcript variant X2
Fanconi anemia group M protein isoform X1
Fanconi anemia group M protein isoform X2
DNA excision repair protein ERCC-1, transcript variant X2
DNA excision repair protein ERCC-1, transcript variant X1
DNA excision repair protein ERCC-1 isoform X1
DNA excision repair protein ERCC-1 isoform X2
uncharacterized LOC125063340, transcript variant X1
uncharacterized protein LOC125063340 isoform X1
uncharacterized LOC125063340, transcript variant X5
uncharacterized protein LOC125063340 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 105 samples with support for all annotated introns
uncharacterized LOC125063364, transcript variant X1
uncharacterized LOC125063364, transcript variant X2
uncharacterized LOC125063340, transcript variant X2
uncharacterized LOC125063340, transcript variant X4
uncharacterized LOC125063340, transcript variant X3
uncharacterized protein LOC125063340 isoform X2
mannosyl-oligosaccharide alpha-1,2-mannosidase IA-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 168 samples with support for all annotated introns
mannosyl-oligosaccharide alpha-1,2-mannosidase IA-like isoform X1
mannosyl-oligosaccharide alpha-1,2-mannosidase IA-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
mannosyl-oligosaccharide alpha-1,2-mannosidase IA-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
CDGSH iron-sulfur domain-containing protein 2 homolog
PH and SEC7 domain-containing protein, transcript variant X1
PH and SEC7 domain-containing protein, transcript variant X2
PH and SEC7 domain-containing protein, transcript variant X3
PH and SEC7 domain-containing protein isoform X1
PH and SEC7 domain-containing protein isoform X2
PH and SEC7 domain-containing protein isoform X3
uncharacterized LOC125048484, transcript variant X2
uncharacterized LOC125048484, transcript variant X1
BRISC and BRCA1-A complex member 1-like, transcript variant X1
BRISC and BRCA1-A complex member 1-like, transcript variant X2
BRISC and BRCA1-A complex member 1-like isoform X2
BRISC and BRCA1-A complex member 1-like isoform X1
tubby-related protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
tubby-related protein 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
tubby-related protein 4, transcript variant X1
tubby-related protein 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
interleukin-1 receptor-associated kinase 4-like
tetratricopeptide repeat protein 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tetratricopeptide repeat protein 12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
tetratricopeptide repeat protein 12 isoform X2
tetratricopeptide repeat protein 12 isoform X1
disintegrin and metalloproteinase domain-containing protein 10, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 100 samples with support for all annotated introns
uncharacterized protein LOC125063227 isoform X1
disintegrin and metalloproteinase domain-containing protein 10 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 84 samples with support for all annotated introns
uncharacterized protein LOC125063227 isoform X2
disintegrin and metalloproteinase domain-containing protein 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized protein LOC125063227 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
microtubule-associated protein futsch, transcript variant X1
microtubule-associated protein futsch, transcript variant X2
microtubule-associated protein futsch, transcript variant X3
microtubule-associated protein futsch isoform X1
microtubule-associated protein futsch isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
angiomotin-like protein 2, transcript variant X1
angiomotin-like protein 2, transcript variant X4
angiomotin-like protein 2, transcript variant X2
angiomotin-like protein 2, transcript variant X3
thiosulfate:glutathione sulfurtransferase-like
thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 3, transcript variant X1
thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 3, transcript variant X2
thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 3 isoform X1
thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 3 isoform X2
histone-lysine N-methyltransferase 2C-like, transcript variant X10
histone-lysine N-methyltransferase 2C-like, transcript variant X1
histone-lysine N-methyltransferase 2C-like, transcript variant X4
histone-lysine N-methyltransferase 2C-like, transcript variant X11
histone-lysine N-methyltransferase 2C-like, transcript variant X2
histone-lysine N-methyltransferase 2C-like, transcript variant X8
histone-lysine N-methyltransferase 2C-like, transcript variant X9
histone-lysine N-methyltransferase 2C-like, transcript variant X3
histone-lysine N-methyltransferase 2C-like, transcript variant X7
histone-lysine N-methyltransferase 2C-like, transcript variant X6
histone-lysine N-methyltransferase 2C-like, transcript variant X12
histone-lysine N-methyltransferase 2C-like, transcript variant X5
uncharacterized protein LOC125063461 isoform X10
histone-lysine N-methyltransferase 2C-like isoform X1
histone-lysine N-methyltransferase 2C-like isoform X4
uncharacterized protein LOC125063461 isoform X11
histone-lysine N-methyltransferase 2C-like isoform X2
histone-lysine N-methyltransferase 2C-like isoform X8
histone-lysine N-methyltransferase 2C-like isoform X9
histone-lysine N-methyltransferase 2C-like isoform X3
histone-lysine N-methyltransferase 2C-like isoform X7
histone-lysine N-methyltransferase 2C-like isoform X6
histone-lysine N-methyltransferase 2C-like isoform X12
histone-lysine N-methyltransferase 2C-like isoform X5
GTP-binding protein SAR1b, transcript variant X1
GTP-binding protein SAR1b, transcript variant X2
GTP-binding protein SAR1b, transcript variant X3
cytosolic carboxypeptidase-like protein 5, transcript variant X2
cytosolic carboxypeptidase-like protein 5, transcript variant X6
cytosolic carboxypeptidase-like protein 5, transcript variant X1
cytosolic carboxypeptidase-like protein 5, transcript variant X9
cytosolic carboxypeptidase-like protein 5, transcript variant X3
cytosolic carboxypeptidase-like protein 5, transcript variant X4
cytosolic carboxypeptidase-like protein 5, transcript variant X8
cytosolic carboxypeptidase-like protein 5, transcript variant X7
cytosolic carboxypeptidase-like protein 5, transcript variant X5
cytosolic carboxypeptidase-like protein 5 isoform X3
cytosolic carboxypeptidase-like protein 5 isoform X5
cytosolic carboxypeptidase-like protein 5 isoform X4
cytosolic carboxypeptidase-like protein 5 isoform X1
cytosolic carboxypeptidase-like protein 5 isoform X2
cytosolic carboxypeptidase-like protein 5 isoform X6
cytosolic carboxypeptidase-like protein 5, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC125063744, transcript variant X1
uncharacterized LOC125063744, transcript variant X2
uncharacterized protein LOC125063744 isoform X1
uncharacterized protein LOC125063744 isoform X2
tachykinin-like peptides receptor 99D, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tachykinin-like peptides receptor 99D, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
tachykinin-like peptides receptor 99D, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
tachykinin-like peptides receptor 99D isoform X2
tachykinin-like peptides receptor 99D isoform X3
tachykinin-like peptides receptor 99D isoform X1
probable ubiquitin carboxyl-terminal hydrolase 9, transcript variant X1
probable ubiquitin carboxyl-terminal hydrolase 9, transcript variant X2
probable ubiquitin carboxyl-terminal hydrolase 9
pyruvate kinase-like, transcript variant X3
pyruvate kinase-like, transcript variant X4
pyruvate kinase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
pyruvate kinase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 110 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 100 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 110 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 110 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 75 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
geranylgeranyl pyrophosphate synthase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 166 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X3
calcium-activated potassium channel slowpoke, transcript variant X16
calcium-activated potassium channel slowpoke, transcript variant X4
calcium-activated potassium channel slowpoke, transcript variant X17
calcium-activated potassium channel slowpoke, transcript variant X12
calcium-activated potassium channel slowpoke, transcript variant X10
calcium-activated potassium channel slowpoke, transcript variant X5
calcium-activated potassium channel slowpoke, transcript variant X1
calcium-activated potassium channel slowpoke, transcript variant X14
calcium-activated potassium channel slowpoke, transcript variant X8
calcium-activated potassium channel slowpoke, transcript variant X22
calcium-activated potassium channel slowpoke, transcript variant X24
calcium-activated potassium channel slowpoke, transcript variant X15
calcium-activated potassium channel slowpoke, transcript variant X7
calcium-activated potassium channel slowpoke, transcript variant X2
calcium-activated potassium channel slowpoke, transcript variant X26
calcium-activated potassium channel slowpoke, transcript variant X21
calcium-activated potassium channel slowpoke, transcript variant X23
calcium-activated potassium channel slowpoke, transcript variant X13
calcium-activated potassium channel slowpoke, transcript variant X20
calcium-activated potassium channel slowpoke, transcript variant X11
calcium-activated potassium channel slowpoke, transcript variant X6
calcium-activated potassium channel slowpoke, transcript variant X25
calcium-activated potassium channel slowpoke, transcript variant X19
calcium-activated potassium channel slowpoke, transcript variant X18
calcium-activated potassium channel slowpoke, transcript variant X9
calcium-activated potassium channel slowpoke isoform X8
calcium-activated potassium channel slowpoke isoform X3
calcium-activated potassium channel slowpoke isoform X16
calcium-activated potassium channel slowpoke isoform X4
calcium-activated potassium channel slowpoke isoform X17
calcium-activated potassium channel slowpoke isoform X12
calcium-activated potassium channel slowpoke isoform X22
calcium-activated potassium channel slowpoke isoform X24
calcium-activated potassium channel slowpoke isoform X15
calcium-activated potassium channel slowpoke isoform X7
calcium-activated potassium channel slowpoke isoform X2
calcium-activated potassium channel slowpoke isoform X10
calcium-activated potassium channel slowpoke isoform X5
calcium-activated potassium channel slowpoke isoform X1
calcium-activated potassium channel slowpoke isoform X14
calcium-activated potassium channel slowpoke isoform X26
calcium-activated potassium channel slowpoke isoform X21
calcium-activated potassium channel slowpoke isoform X23
calcium-activated potassium channel slowpoke isoform X13
calcium-activated potassium channel slowpoke isoform X20
calcium-activated potassium channel slowpoke isoform X11
calcium-activated potassium channel slowpoke isoform X6
calcium-activated potassium channel slowpoke isoform X25
calcium-activated potassium channel slowpoke isoform X19
calcium-activated potassium channel slowpoke isoform X18
calcium-activated potassium channel slowpoke isoform X9
uncharacterized LOC125063400, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein LOC125063400 isoform X2
uncharacterized LOC125063400, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized protein LOC125063400 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 94 samples with support for all annotated introns
uncharacterized LOC125063739, transcript variant X2
uncharacterized LOC125063739, transcript variant X1
uncharacterized LOC125063739, transcript variant X3
uncharacterized protein LOC125063739 isoform X3
uncharacterized protein LOC125063739 isoform X2
uncharacterized protein LOC125063739 isoform X1
uncharacterized LOC125063533, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC125063533, transcript variant X2
uncharacterized protein LOC125063533 isoform X1
uncharacterized protein LOC125063533 isoform X2
methionine aminopeptidase 1, transcript variant X2
methionine aminopeptidase 1, transcript variant X1
tolloid-like protein 1, transcript variant X3
tolloid-like protein 1, transcript variant X2
tolloid-like protein 1, transcript variant X1
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 69 samples with support for all annotated introns
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X7
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 167 samples with support for all annotated introns
calcium-binding mitochondrial carrier protein Aralar1 isoform X6
calcium-binding mitochondrial carrier protein Aralar1 isoform X1
calcium-binding mitochondrial carrier protein Aralar1 isoform X2
calcium-binding mitochondrial carrier protein Aralar1 isoform X3
calcium-binding mitochondrial carrier protein Aralar1 isoform X4
calcium-binding mitochondrial carrier protein Aralar1 isoform X5
calcium-binding mitochondrial carrier protein Aralar1 isoform X7
oxamate amidohydrolase proenzyme-like, transcript variant X3
oxamate amidohydrolase proenzyme-like, transcript variant X2
oxamate amidohydrolase proenzyme-like, transcript variant X1
oxamate amidohydrolase proenzyme-like isoform X1
oxamate amidohydrolase proenzyme-like isoform X2
acid sphingomyelinase-like phosphodiesterase 3a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC125063543, transcript variant X4
uncharacterized LOC125063543, transcript variant X3
uncharacterized LOC125063543, transcript variant X2
uncharacterized LOC125063543, transcript variant X1
uncharacterized protein LOC125063543 isoform X4
uncharacterized protein LOC125063543 isoform X3
uncharacterized protein LOC125063543 isoform X2
uncharacterized protein LOC125063543 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
centaurin-gamma-1A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
centaurin-gamma-1A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 69 samples with support for all annotated introns
centaurin-gamma-1A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
angiotensin-converting enzyme-like, transcript variant X2
angiotensin-converting enzyme-like, transcript variant X3
angiotensin-converting enzyme-like, transcript variant X1
angiotensin-converting enzyme-like isoform X3
angiotensin-converting enzyme-like isoform X1
angiotensin-converting enzyme-like isoform X2
angiotensin-converting enzyme-like, transcript variant X4
angiotensin-converting enzyme-like isoform X4
uncharacterized protein PB18E9.04c, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 59 samples with support for all annotated introns
uncharacterized protein PB18E9.04c, transcript variant X1
uncharacterized protein PB18E9.04c, transcript variant X3
uncharacterized protein PB18E9.04c isoform X1
uncharacterized protein LOC125063166 isoform X3
uncharacterized protein PB18E9.04c isoform X2
juvenile hormone esterase-like, transcript variant X1
juvenile hormone esterase-like, transcript variant X2
juvenile hormone esterase-like isoform X1
juvenile hormone esterase-like isoform X2
importin subunit alpha-7, transcript variant X2
importin subunit alpha-7, transcript variant X1
ATP synthase subunit beta, mitochondrial-like
ubiquinol-cytochrome-c reductase complex assembly factor 1
ATP synthase subunit beta, mitochondrial
zinc finger protein 800, transcript variant X3
zinc finger protein 800, transcript variant X1
zinc finger protein 800, transcript variant X2
NEDD8-activating enzyme E1 catalytic subunit, transcript variant X1
NEDD8-activating enzyme E1 catalytic subunit, transcript variant X2
NEDD8-activating enzyme E1 catalytic subunit isoform X1
NEDD8-activating enzyme E1 catalytic subunit isoform X2
signal peptidase complex catalytic subunit SEC11A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
venom allergen 3-like, transcript variant X1
venom allergen 3-like, transcript variant X3
venom allergen 3-like, transcript variant X2
serine protease nudel, transcript variant X2
serine protease nudel, transcript variant X3
serine protease nudel, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
corticotropin-releasing factor-binding protein
acetylcholinesterase-like, transcript variant X2
acetylcholinesterase-like, transcript variant X1
protein bric-a-brac 1-like, transcript variant X3
protein bric-a-brac 1-like, transcript variant X2
protein bric-a-brac 1-like, transcript variant X1
uncharacterized protein LOC125063734 isoform X1
protein bric-a-brac 1-like, transcript variant X4
uncharacterized LOC125063285, transcript variant X1
uncharacterized LOC125063285, transcript variant X2
venom allergen 5-like, transcript variant X3
uncharacterized LOC125063276, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized LOC125063276, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
venom allergen 5-like, transcript variant X2
venom allergen 5-like, transcript variant X1
uncharacterized LOC125063275, transcript variant X3
uncharacterized LOC125063275, transcript variant X4
uncharacterized LOC125063275, transcript variant X1
uncharacterized protein LOC125063275 isoform X3
uncharacterized protein LOC125063275 isoform X1
uncharacterized LOC125063275, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 144 samples with support for all annotated introns
uncharacterized protein LOC125063275 isoform X2
putative serine protease K12H4.7, transcript variant X1
putative serine protease K12H4.7, transcript variant X2
putative serine protease K12H4.7 isoform X1
putative serine protease K12H4.7 isoform X2
S-adenosylmethionine synthase, transcript variant X1
S-adenosylmethionine synthase, transcript variant X2
S-adenosylmethionine synthase isoform X1
S-adenosylmethionine synthase isoform X2
gastric inhibitory polypeptide receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments
PHD finger protein 14, transcript variant X1
PHD finger protein 14, transcript variant X8
PHD finger protein 14, transcript variant X5
PHD finger protein 14, transcript variant X2
PHD finger protein 14, transcript variant X9
PHD finger protein 14, transcript variant X6
PHD finger protein 14, transcript variant X3
PHD finger protein 14, transcript variant X7
PHD finger protein 14, transcript variant X10
PHD finger protein 14, transcript variant X11
PHD finger protein 14, transcript variant X4
arylsulfatase B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
arylsulfatase B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 72 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
arylsulfatase B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
arylsulfatase B-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 168 samples with support for all annotated introns
transcription initiation factor TFIID subunit 13, transcript variant X6
transcription initiation factor TFIID subunit 13, transcript variant X2
transcription initiation factor TFIID subunit 13, transcript variant X4
transcription initiation factor TFIID subunit 13, transcript variant X1
transcription initiation factor TFIID subunit 13, transcript variant X3
transcription initiation factor TFIID subunit 13, transcript variant X5
transcription initiation factor TFIID subunit 13
uncharacterized LOC125063232, transcript variant X2
uncharacterized LOC125063232, transcript variant X1
uncharacterized LOC125063232, transcript variant X3
uncharacterized protein LOC125063232 isoform X3
uncharacterized protein LOC125063232 isoform X2
uncharacterized protein LOC125063232 isoform X1
uncharacterized LOC125063233, transcript variant X2
uncharacterized LOC125063233, transcript variant X1
uncharacterized protein LOC125063233 isoform X1
uncharacterized LOC125063233, transcript variant X4
uncharacterized LOC125063233, transcript variant X5
uncharacterized LOC125063233, transcript variant X3
uncharacterized protein LOC125063233 isoform X2
glutamate-gated chloride channel, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X6
glutamate-gated chloride channel, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate-gated chloride channel, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate-gated chloride channel, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X9
glutamate-gated chloride channel, transcript variant X10
glutamate-gated chloride channel, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate-gated chloride channel, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X2
glutamate-gated chloride channel, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X3
glutamate-gated chloride channel, transcript variant X1
glutamate-gated chloride channel isoform X19
glutamate-gated chloride channel isoform X18
glutamate-gated chloride channel isoform X13
glutamate-gated chloride channel isoform X17
glutamate-gated chloride channel isoform X14
glutamate-gated chloride channel subunit beta isoform X6
glutamate-gated chloride channel subunit beta isoform X20
glutamate-gated chloride channel isoform X15
glutamate-gated chloride channel isoform X11
glutamate-gated chloride channel isoform X21
glutamate-gated chloride channel isoform X16
glutamate-gated chloride channel isoform X12
glutamate-gated chloride channel isoform X5
glutamate-gated chloride channel isoform X9
glutamate-gated chloride channel isoform X10
glutamate-gated chloride channel subunit beta isoform X8
glutamate-gated chloride channel subunit beta isoform X7
glycine receptor subunit alpha-3 isoform X2
glycine receptor subunit alpha-3 isoform X4
glutamate-gated chloride channel subunit beta isoform X3
glutamate-gated chloride channel subunit beta isoform X1
glutamate-gated chloride channel, transcript variant X16
glutamate-gated chloride channel, transcript variant X11
poly(rC)-binding protein 3, transcript variant X8
poly(rC)-binding protein 3, transcript variant X9
poly(rC)-binding protein 3, transcript variant X4
poly(rC)-binding protein 3, transcript variant X3
poly(rC)-binding protein 3, transcript variant X1
poly(rC)-binding protein 3, transcript variant X5
poly(rC)-binding protein 3, transcript variant X6
poly(rC)-binding protein 3, transcript variant X7
poly(rC)-binding protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 9% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
molybdenum cofactor sulfurase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
molybdenum cofactor sulfurase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 134 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 166 samples with support for all annotated introns
sorbin and SH3 domain-containing protein 1, transcript variant X10
sorbin and SH3 domain-containing protein 1, transcript variant X12
sorbin and SH3 domain-containing protein 1, transcript variant X11
sorbin and SH3 domain-containing protein 1 isoform X10
sorbin and SH3 domain-containing protein 1 isoform X12
sorbin and SH3 domain-containing protein 1 isoform X11
sorbin and SH3 domain-containing protein 1, transcript variant X13
sorbin and SH3 domain-containing protein 1 isoform X13
sorbin and SH3 domain-containing protein 1, transcript variant X1
sorbin and SH3 domain-containing protein 1, transcript variant X5
sorbin and SH3 domain-containing protein 1, transcript variant X6
sorbin and SH3 domain-containing protein 1, transcript variant X7
sorbin and SH3 domain-containing protein 1, transcript variant X9
sorbin and SH3 domain-containing protein 1, transcript variant X2
sorbin and SH3 domain-containing protein 1, transcript variant X14
sorbin and SH3 domain-containing protein 1, transcript variant X8
sorbin and SH3 domain-containing protein 1, transcript variant X3
sorbin and SH3 domain-containing protein 1, transcript variant X4
uncharacterized protein LOC125063775 isoform X1
uncharacterized protein LOC125063775 isoform X5
uncharacterized protein LOC125063775 isoform X6
uncharacterized protein LOC125063775 isoform X7
uncharacterized protein LOC125063775 isoform X9
uncharacterized protein LOC125063775 isoform X2
uncharacterized protein LOC125063775 isoform X14
uncharacterized protein LOC125063775 isoform X8
uncharacterized protein LOC125063775 isoform X3
uncharacterized protein LOC125063775 isoform X4
putative sodium-dependent multivitamin transporter, transcript variant X1
putative sodium-dependent multivitamin transporter, transcript variant X2
putative sodium-dependent multivitamin transporter
putative sodium-dependent multivitamin transporter, transcript variant X4
putative sodium-dependent multivitamin transporter, transcript variant X3
putative sodium-dependent multivitamin transporter isoform X2
putative sodium-dependent multivitamin transporter isoform X1
putative sodium-dependent multivitamin transporter isoform X4
putative sodium-dependent multivitamin transporter isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC125063746, transcript variant X1
uncharacterized LOC125063746, transcript variant X2
uncharacterized protein LOC125063746 isoform X1
uncharacterized protein LOC125063746 isoform X2
cell division cycle and apoptosis regulator protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 164 samples with support for all annotated introns
uncharacterized LOC125063138, transcript variant X2
uncharacterized LOC125063138, transcript variant X1
uncharacterized protein LOC125063138 isoform X1
uncharacterized protein LOC125063138 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC125063121, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized protein LOC125063121 isoform X1
uncharacterized LOC125063121, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
uncharacterized LOC125063121, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized protein LOC125063121 isoform X2
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
acidic leucine-rich nuclear phosphoprotein 32 family member A, transcript variant X1
acidic leucine-rich nuclear phosphoprotein 32 family member A, transcript variant X2
acidic leucine-rich nuclear phosphoprotein 32 family member A isoform X1
acidic leucine-rich nuclear phosphoprotein 32 family member A isoform X2
huntingtin-interacting protein K, transcript variant X2
huntingtin-interacting protein K, transcript variant X1
uncharacterized LOC125063223, transcript variant X1
uncharacterized LOC125063223, transcript variant X2
uncharacterized protein LOC125063223 isoform X1
uncharacterized protein LOC125063223 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
guanine nucleotide-binding protein G(q) subunit alpha, transcript variant X6
guanine nucleotide-binding protein G(q) subunit alpha, transcript variant X2
guanine nucleotide-binding protein G(q) subunit alpha, transcript variant X1
guanine nucleotide-binding protein G(q) subunit alpha, transcript variant X5
guanine nucleotide-binding protein G(q) subunit alpha isoform X2
guanine nucleotide-binding protein G(q) subunit alpha isoform X1
guanine nucleotide-binding protein G(q) subunit alpha isoform X5
guanine nucleotide-binding protein G(q) subunit alpha, transcript variant X4
guanine nucleotide-binding protein G(q) subunit alpha, transcript variant X3
fatty-acid amide hydrolase 2-B-like, transcript variant X2
fatty-acid amide hydrolase 2-B-like, transcript variant X1
fatty-acid amide hydrolase 2-B-like isoform X1
fatty-acid amide hydrolase 2-B-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger MIZ domain-containing protein 1, transcript variant X1
zinc finger MIZ domain-containing protein 1, transcript variant X2
zinc finger MIZ domain-containing protein 1, transcript variant X3
zinc finger MIZ domain-containing protein 1 isoform X1
zinc finger MIZ domain-containing protein 1 isoform X2
uncharacterized LOC125063140, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 119 samples with support for all annotated introns
uncharacterized LOC125063140, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
uncharacterized protein LOC125063140 isoform X1
uncharacterized LOC125063140, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 83 samples with support for all annotated introns
uncharacterized protein LOC125063140 isoform X2
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial, transcript variant X5
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial, transcript variant X2
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial, transcript variant X1
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial, transcript variant X4
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial, transcript variant X3
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial isoform X4
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial isoform X3
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial isoform X2
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial isoform X5
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial isoform X1
polypeptide N-acetylgalactosaminyltransferase 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 168 samples with support for all annotated introns
polypeptide N-acetylgalactosaminyltransferase 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
polypeptide N-acetylgalactosaminyltransferase 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 132 samples with support for all annotated introns
polypeptide N-acetylgalactosaminyltransferase 5 isoform X1
polypeptide N-acetylgalactosaminyltransferase 5 isoform X2
mitogen-activated protein kinase kinase kinase 7
potassium channel AKT6-like, transcript variant X1
potassium channel AKT6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC125063247 isoform X2
putative neuropeptide precursor protein, transcript variant X1
putative neuropeptide precursor protein, transcript variant X2
putative neuropeptide precursor protein isoform X2
putative neuropeptide precursor protein isoform X1
peptidyl-prolyl cis-trans isomerase sig-7
carboxypeptidase B-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
carboxypeptidase B-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
carboxypeptidase B-like, transcript variant X4
carboxypeptidase B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
carboxypeptidase B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
carboxypeptidase B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
runt-related transcription factor 3, transcript variant X2
runt-related transcription factor 3, transcript variant X1
runt-related transcription factor 3 isoform X2
runt-related transcription factor 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments
runt-related transcription factor 1-like
pre-mRNA-splicing regulator female-lethal(2)D
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized LOC125063662, transcript variant X2
uncharacterized LOC125063662, transcript variant X1
uncharacterized LOC125063662, transcript variant X4
uncharacterized LOC125063662, transcript variant X3
uncharacterized protein LOC125063662 isoform X1
uncharacterized protein LOC125063662 isoform X2
probable ribonuclease ZC3H12C, transcript variant X1
probable ribonuclease ZC3H12C, transcript variant X2
probable ribonuclease ZC3H12C isoform X1
probable ribonuclease ZC3H12C isoform X2
NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial, transcript variant X1
NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial, transcript variant X2
NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial
reversion-inducing cysteine-rich protein with Kazal motifs
brefeldin A-inhibited guanine nucleotide-exchange protein 3
uncharacterized LOC125063501, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized LOC125063501, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial
endothelial lipase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
endothelial lipase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
pancreatic triacylglycerol lipase isoform X1
malate dehydrogenase-like, transcript variant X1
malate dehydrogenase-like, transcript variant X2
transfer RNA tyrosine (anticodon GUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon UGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 149 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
probable ATP-dependent RNA helicase DDX46, transcript variant X1
probable ATP-dependent RNA helicase DDX46
probable ATP-dependent RNA helicase DDX46, transcript variant X2
U6 snRNA-associated Sm-like protein LSm3
U3 small nucleolar RNA-associated protein 14 homolog A
type-2 histone deacetylase 2-like, transcript variant X3
type-2 histone deacetylase 2-like, transcript variant X2
type-2 histone deacetylase 2-like, transcript variant X4
type-2 histone deacetylase 2-like, transcript variant X1
type-2 histone deacetylase 2-like isoform X3
uncharacterized protein LOC125063117 isoform X2
uncharacterized protein LOC125063117 isoform X4
uncharacterized protein LOC125063117 isoform X1
isocitrate dehydrogenase [NAD] subunit beta, mitochondrial, transcript variant X1
isocitrate dehydrogenase [NAD] subunit beta, mitochondrial, transcript variant X2
isocitrate dehydrogenase [NAD] subunit beta, mitochondrial isoform X1
isocitrate dehydrogenase [NAD] subunit beta, mitochondrial isoform X2
ileal sodium/bile acid cotransporter-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ileal sodium/bile acid cotransporter-like, transcript variant X1
ileal sodium/bile acid cotransporter-like
sodium/bile acid cotransporter-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 150 samples with support for all annotated introns
sodium/bile acid cotransporter-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
sodium/bile acid cotransporter-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 120 samples with support for all annotated introns
sodium/bile acid cotransporter-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 112 samples with support for all annotated introns
sodium/bile acid cotransporter-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 128 samples with support for all annotated introns
sodium/bile acid cotransporter-like isoform X3
sodium/bile acid cotransporter-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 76 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 99 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
homeobox protein MSX-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
homeobox protein MSX-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 82 samples with support for all annotated introns
muscle segmentation homeobox-like isoform X1
general transcription factor IIH subunit 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 81 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
protein polybromo-1, transcript variant X2
protein polybromo-1, transcript variant X7
protein polybromo-1, transcript variant X1
protein polybromo-1, transcript variant X6
protein polybromo-1, transcript variant X8
protein polybromo-1, transcript variant X3
protein polybromo-1, transcript variant X4
protein polybromo-1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA alanine (anticodon AGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
28S ribosomal protein S10, mitochondrial
gastrula zinc finger protein XlCGF17.1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
dosage compensation regulator, transcript variant X2
dosage compensation regulator, transcript variant X1
dosage compensation regulator, transcript variant X3
dosage compensation regulator, transcript variant X4
dosage compensation regulator isoform X2
dosage compensation regulator isoform X1
dosage compensation regulator isoform X3
dosage compensation regulator isoform X4
protein fem-1 homolog C, transcript variant X2
protein fem-1 homolog C, transcript variant X1
protein Skeletor, isoforms B/C, transcript variant X4
protein Skeletor, isoforms B/C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 132 samples with support for all annotated introns
protein Skeletor, isoforms B/C, transcript variant X2
protein Skeletor, isoforms B/C, transcript variant X1
protein Skeletor, isoforms D/E isoform X1
protein Skeletor, isoforms B/C isoform X3
protein Skeletor, isoforms B/C isoform X2
protein Skeletor, isoforms B/C isoform X4
ankyrin repeat domain-containing protein 50
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 168 samples with support for all annotated introns
dynein axonemal assembly factor 1 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dynein axonemal assembly factor 1 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dynein axonemal assembly factor 1 homolog, transcript variant X1
dynein axonemal assembly factor 1 homolog isoform X3
dynein axonemal assembly factor 1 homolog isoform X2
dynein axonemal assembly factor 1 homolog isoform X1
clathrin interactor 1, transcript variant X2
clathrin interactor 1, transcript variant X1
telomere length regulation protein TEL2 homolog isoform X1
protein Skeletor, isoforms B/C, transcript variant X5
protein Skeletor, isoforms B/C isoform X5
protein Skeletor, isoforms B/C isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 165 samples with support for all annotated introns
aminopeptidase N-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
aminopeptidase N-like, transcript variant X2
biorientation of chromosomes in cell division protein 1-like 1, transcript variant X2
biorientation of chromosomes in cell division protein 1-like 1 isoform X2
uncharacterized LOC125063493, transcript variant X2
uncharacterized LOC125063493, transcript variant X1
uncharacterized protein LOC125063493 isoform X2
uncharacterized protein LOC125063493 isoform X1
glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial
biorientation of chromosomes in cell division protein 1-like 1, transcript variant X1
biorientation of chromosomes in cell division protein 1-like 1 isoform X1
succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial
28S ribosomal protein S18c, mitochondrial
ABC transporter G family member 23, transcript variant X1
ABC transporter G family member 23 isoform X1
ABC transporter G family member 23, transcript variant X2
ABC transporter G family member 23 isoform X2
nucleolar protein 12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
nucleolar protein 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 135 samples with support for all annotated introns
protein starmaker, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 141 samples with support for all annotated introns
protein starmaker, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 162 samples with support for all annotated introns
uncharacterized protein DDB_G0284459 isoform X1
cilia- and flagella-associated protein 206
upstream activation factor subunit spp27, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 161 samples with support for all annotated introns
upstream activation factor subunit spp27, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 160 samples with support for all annotated introns
upstream activation factor subunit spp27 isoform X2
upstream activation factor subunit spp27 isoform X1
translocator protein-like, transcript variant X2
translocator protein-like, transcript variant X3
translocator protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 56% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125063127, transcript variant X2
uncharacterized LOC125063127, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF01262
transfer RNA isoleucine (anticodon UAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
TGF-beta-activated kinase 1 and MAP3K7-binding protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
transcription factor BTF3 homolog 4-like
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1, transcript variant X2
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1, transcript variant X4
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1, transcript variant X5
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3 isoform X2
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 isoform X5
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3 isoform X4
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1, transcript variant X3
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1, transcript variant X1
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3 isoform X1
uncharacterized protein LOC125063475 isoform X3
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 108 samples with support for all annotated introns
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 isoform X6
zinc finger protein on ecdysone puffs, transcript variant X5
zinc finger protein on ecdysone puffs, transcript variant X4
zinc finger protein on ecdysone puffs, transcript variant X3
zinc finger protein on ecdysone puffs, transcript variant X2
zinc finger protein on ecdysone puffs, transcript variant X1
zinc finger protein on ecdysone puffs isoform X5
zinc finger protein on ecdysone puffs isoform X4
zinc finger protein on ecdysone puffs isoform X3
zinc finger protein on ecdysone puffs isoform X2
zinc finger protein on ecdysone puffs isoform X1
large neutral amino acids transporter small subunit 1
NADPH-dependent diflavin oxidoreductase 1, transcript variant X1
NADPH-dependent diflavin oxidoreductase 1, transcript variant X2
NADPH-dependent diflavin oxidoreductase 1 isoform X1
NADPH-dependent diflavin oxidoreductase 1 isoform X2
U3 small nucleolar ribonucleoprotein protein IMP4
uncharacterized LOC125063611, transcript variant X1
uncharacterized LOC125063611, transcript variant X2
uncharacterized protein LOC125063611 isoform X1
uncharacterized protein LOC125063611 isoform X2
G protein-coupled receptor kinase 2, transcript variant X1
G protein-coupled receptor kinase 2, transcript variant X2
G protein-coupled receptor kinase 2 isoform X1
G protein-coupled receptor kinase 2 isoform X2
myosin tail region-interacting protein MTI1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 104 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 165 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
erythroid differentiation-related factor 1
facilitated trehalose transporter Tret1, transcript variant X2
facilitated trehalose transporter Tret1, transcript variant X1
facilitated trehalose transporter Tret1, transcript variant X3
facilitated trehalose transporter Tret1 isoform X1
facilitated trehalose transporter Tret1 isoform X2
facilitated trehalose transporter Tret1-like
DNA-directed RNA polymerase I subunit RPA2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC125063336, transcript variant X1
uncharacterized LOC125063336, transcript variant X2
uncharacterized protein LOC125063336 isoform X1
uncharacterized protein LOC125063336 isoform X2
tetraspanin-33-like, transcript variant X1
tetraspanin-33-like, transcript variant X2
mushroom body large-type Kenyon cell-specific protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
mushroom body large-type Kenyon cell-specific protein 1 isoform X1
mushroom body large-type Kenyon cell-specific protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 80 samples with support for all annotated introns
mushroom body large-type Kenyon cell-specific protein 1 isoform X2
attractin-like protein 1, transcript variant X1
attractin-like protein 1, transcript variant X2
allergen Tab y 5.0101-like, transcript variant X2
allergen Tab y 5.0101-like, transcript variant X1
vacuolar protein sorting-associated protein 16B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 154 samples with support for all annotated introns
transfer RNA proline (anticodon UGG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
facilitated trehalose transporter Tret1-like, transcript variant X4
facilitated trehalose transporter Tret1-like, transcript variant X3
facilitated trehalose transporter Tret1-like, transcript variant X6
facilitated trehalose transporter Tret1-like, transcript variant X1
facilitated trehalose transporter Tret1-like, transcript variant X2
facilitated trehalose transporter Tret1-like, transcript variant X7
facilitated trehalose transporter Tret1-like, transcript variant X5
facilitated trehalose transporter Tret1-like isoform X1
ornithine transcarbamylase, mitochondrial-like isoform X2
probable 28S ribosomal protein S25, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
uncharacterized LOC125063790, transcript variant X2
uncharacterized LOC125063790, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 82 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 99 samples with support for all annotated introns
protein phosphatase PP2A 55 kDa regulatory subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
protein phosphatase PP2A 55 kDa regulatory subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
protein phosphatase PP2A 55 kDa regulatory subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
protein phosphatase PP2A 55 kDa regulatory subunit, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 158 samples with support for all annotated introns
protein phosphatase PP2A 55 kDa regulatory subunit, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 125 samples with support for all annotated introns
protein phosphatase PP2A 55 kDa regulatory subunit, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X1
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X2
protein phosphatase PP2A 55 kDa regulatory subunit isoform X6
protein phosphatase PP2A 55 kDa regulatory subunit isoform X4
protein phosphatase PP2A 55 kDa regulatory subunit isoform X5
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X3
uncharacterized LOC125063713, transcript variant X2
uncharacterized LOC125063713, transcript variant X1
uncharacterized protein LOC125063713 isoform X1
uncharacterized protein LOC125063713 isoform X2
probable small nuclear ribonucleoprotein Sm D2
disintegrin and metalloproteinase domain-containing protein 12
glycerol-3-phosphate acyltransferase 1, mitochondrial, transcript variant X5
glycerol-3-phosphate acyltransferase 1, mitochondrial, transcript variant X6
glycerol-3-phosphate acyltransferase 1, mitochondrial, transcript variant X2
glycerol-3-phosphate acyltransferase 1, mitochondrial, transcript variant X4
glycerol-3-phosphate acyltransferase 1, mitochondrial, transcript variant X3
glycerol-3-phosphate acyltransferase 1, mitochondrial, transcript variant X1
glycerol-3-phosphate acyltransferase 1, mitochondrial isoform X1
glycerol-3-phosphate acyltransferase 1, mitochondrial isoform X2
xenotropic and polytropic retrovirus receptor 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
uncharacterized LOC125063122, transcript variant X2
uncharacterized LOC125063122, transcript variant X1
uncharacterized protein LOC125063122 isoform X1
uncharacterized protein LOC125063122 isoform X2
zinc finger and BTB domain-containing protein 24-like, transcript variant X2
zinc finger and BTB domain-containing protein 24-like, transcript variant X1
zinc finger and BTB domain-containing protein 24-like isoform X1
phosphatidylinositide phosphatase SAC2, transcript variant X1
phosphatidylinositide phosphatase SAC2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
phosphatidylinositide phosphatase SAC2 isoform X1
phosphatidylinositide phosphatase SAC2 isoform X2
equilibrative nucleoside transporter 1, transcript variant X1
equilibrative nucleoside transporter 1 isoform X1
equilibrative nucleoside transporter 1, transcript variant X2
equilibrative nucleoside transporter 1 isoform X2
uncharacterized LOC125063596, transcript variant X2
uncharacterized LOC125063596, transcript variant X1
uncharacterized protein LOC125063596 isoform X2
uncharacterized protein LOC125063596 isoform X1
uncharacterized LOC125063519, transcript variant X1
uncharacterized LOC125063519, transcript variant X2
uncharacterized protein LOC125063519 isoform X1
uncharacterized protein LOC125063519 isoform X2
insulin-like growth factor-binding protein complex acid labile subunit
vesicular integral-membrane protein VIP36
uncharacterized LOC125063673, transcript variant X2
uncharacterized LOC125063673, transcript variant X1
uncharacterized protein LOC125063673 isoform X1
uncharacterized protein LOC125063673 isoform X2
FMRFamide receptor-like, transcript variant X1
FMRFamide receptor-like, transcript variant X2
vegetative cell wall protein gp1-like, transcript variant X1
vegetative cell wall protein gp1-like, transcript variant X2
vegetative cell wall protein gp1-like, transcript variant X3
serine/arginine repetitive matrix protein 1-like isoform X1
vegetative cell wall protein gp1-like isoform X2
delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial
cell division cycle 7-related protein kinase-like
CDGSH iron-sulfur domain-containing protein 3, mitochondrial
uncharacterized LOC125048476, transcript variant X4
uncharacterized LOC125048476, transcript variant X1
uncharacterized LOC125048476, transcript variant X3
uncharacterized LOC125048476, transcript variant X7
uncharacterized LOC125048476, transcript variant X2
uncharacterized LOC125048476, transcript variant X5
uncharacterized LOC125048476, transcript variant X6
uncharacterized LOC125048476, transcript variant X8
uncharacterized protein LOC125048476 isoform X1
uncharacterized protein LOC125048476 isoform X3
uncharacterized protein LOC125048476 isoform X7
uncharacterized protein LOC125048476 isoform X2
uncharacterized protein LOC125048476 isoform X5
uncharacterized protein LOC125048476 isoform X6
uncharacterized protein LOC125048476 isoform X4
uncharacterized protein LOC125048476 isoform X8
U11/U12 small nuclear ribonucleoprotein 35 kDa protein-like
raf homolog serine/threonine-protein kinase Raf, transcript variant X1
raf homolog serine/threonine-protein kinase Raf, transcript variant X2
raf homolog serine/threonine-protein kinase Raf isoform X1
raf homolog serine/threonine-protein kinase Raf isoform X2
nose resistant to fluoxetine protein 6-like
dual specificity protein phosphatase MPK-4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 88 samples with support for all annotated introns
zinc finger protein 771-like, transcript variant X1
zinc finger protein 771-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
ecdysone-induced protein 74EF, transcript variant X4
ecdysone-induced protein 74EF, transcript variant X1
ecdysone-induced protein 74EF, transcript variant X5
ecdysone-induced protein 74EF, transcript variant X2
ecdysone-induced protein 74EF, transcript variant X3
U7 snRNA-associated Sm-like protein LSm11
ecdysone-induced protein 74EF isoform X2
ecdysone-induced protein 74EF isoform X1
ecdysone-induced protein 74EF isoform X3
ecdysone-induced protein 74EF, transcript variant X6
ecdysone-induced protein 74EF isoform X4
mitochondrial mRNA pseudouridine synthase Trub2
uncharacterized protein LOC125063290 isoform X1
uncharacterized protein LOC125063290 isoform X2
uncharacterized protein LOC125063290 isoform X3
uncharacterized LOC125063630, transcript variant X2
uncharacterized LOC125063630, transcript variant X1
ubiquitin carboxyl-terminal hydrolase MINDY-3 homolog
U3 small nucleolar ribonucleoprotein protein IMP3
cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2
NK1 transcription factor-related protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
innexin shaking-B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
innexin shaking-B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
innexin shaking-B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
innexin shaking-B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 114 samples with support for all annotated introns
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
tRNA N(3)-methylcytidine methyltransferase METTL6, transcript variant X4
tRNA N(3)-methylcytidine methyltransferase METTL6, transcript variant X3
tRNA N(3)-methylcytidine methyltransferase METTL6, transcript variant X2
tRNA N(3)-methylcytidine methyltransferase METTL6, transcript variant X1
small nucleolar RNA snR60/Z15/Z230/Z193/J17
COORDINATES: nucleotide motif:Rfam:12.0:RF00309
tRNA N(3)-methylcytidine methyltransferase METTL6 isoform X2
tRNA N(3)-methylcytidine methyltransferase METTL6 isoform X1
116 kDa U5 small nuclear ribonucleoprotein component
probable low affinity copper uptake protein 2, transcript variant X1
uncharacterized protein LOC125063455 isoform X1
probable low affinity copper uptake protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
probable low affinity copper uptake protein 2 isoform X2
folylpolyglutamate synthase, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 163 samples with support for all annotated introns
putative RNA polymerase II subunit B1 CTD phosphatase RPAP2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
histone-lysine N-methyltransferase EHMT1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
histone-lysine N-methyltransferase EHMT1, transcript variant X2
histone-lysine N-methyltransferase EHMT1 isoform X1
histone-lysine N-methyltransferase EHMT1 isoform X2
uncharacterized LOC125063539, transcript variant X1
uncharacterized LOC125063539, transcript variant X2
spectrin alpha chain, transcript variant X4
spectrin alpha chain, transcript variant X3
spectrin alpha chain, transcript variant X2
spectrin alpha chain, transcript variant X1
homeobox protein extradenticle, transcript variant X1
homeobox protein extradenticle, transcript variant X2
homeobox protein extradenticle, transcript variant X4
homeobox protein extradenticle, transcript variant X3
homeobox protein extradenticle isoform X4
homeobox protein extradenticle isoform X3
homeobox protein extradenticle isoform X2
homeobox protein extradenticle isoform X1
pre-mRNA-splicing factor 38B, transcript variant X1
pre-mRNA-splicing factor 38B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 139 samples with support for all annotated introns
ubiquitin-like protein 5, transcript variant X1
ubiquitin-like protein 5, transcript variant X2
uncharacterized LOC125063153, transcript variant X1
uncharacterized LOC125063153, transcript variant X3
uncharacterized LOC125063153, transcript variant X2
uncharacterized protein LOC125063153 isoform X1
uncharacterized protein LOC125063153 isoform X2
nonsense-mediated mRNA decay factor SMG7-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 168 samples with support for all annotated introns
BTB/POZ and MATH domain-containing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
DNA-directed RNA polymerase II subunit RPB9
receptor-mediated endocytosis protein 6 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
dual specificity mitogen-activated protein kinase kinase 7, transcript variant X1
dual specificity mitogen-activated protein kinase kinase 7, transcript variant X2
dual specificity mitogen-activated protein kinase kinase 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
dual specificity mitogen-activated protein kinase kinase 7 isoform X1
dual specificity mitogen-activated protein kinase kinase 7 isoform X2
dual specificity mitogen-activated protein kinase kinase 7 isoform X3
uridine-cytidine kinase, transcript variant X1
uridine-cytidine kinase, transcript variant X2
uridine-cytidine kinase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 161 samples with support for all annotated introns
amidophosphoribosyltransferase-like, transcript variant X1
amidophosphoribosyltransferase-like, transcript variant X4
amidophosphoribosyltransferase-like, transcript variant X2
amidophosphoribosyltransferase-like, transcript variant X3
amidophosphoribosyltransferase-like isoform X1
amidophosphoribosyltransferase-like isoform X2
casein kinase II subunit beta, transcript variant X1
casein kinase II subunit beta, transcript variant X2
casein kinase II subunit beta isoform X1
casein kinase II subunit beta, transcript variant X3
casein kinase II subunit beta isoform X2
uncharacterized LOC125063268, transcript variant X1
uncharacterized LOC125063268, transcript variant X4
uncharacterized LOC125063268, transcript variant X3
uncharacterized LOC125063268, transcript variant X2
cysteine-rich with EGF-like domain protein 2, transcript variant X1
cysteine-rich with EGF-like domain protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 138 samples with support for all annotated introns
cysteine-rich with EGF-like domain protein 2 isoform X1
cysteine-rich with EGF-like domain protein 2 isoform X2
uncharacterized protein LOC125063268 isoform X1
uncharacterized protein LOC125063268 isoform X2
uncharacterized LOC125063402, transcript variant X2
uncharacterized LOC125063402, transcript variant X1
uncharacterized LOC125063402, transcript variant X6
uncharacterized LOC125063402, transcript variant X7
uncharacterized protein LOC125063402 isoform X2
uncharacterized protein LOC125063402 isoform X1
uncharacterized protein LOC125063402 isoform X5
uncharacterized LOC125063402, transcript variant X3
uncharacterized LOC125063402, transcript variant X4
uncharacterized protein LOC125063402 isoform X3
uncharacterized LOC125063402, transcript variant X5
uncharacterized protein LOC125063402 isoform X4
prion-like-(Q/N-rich) domain-bearing protein 25, transcript variant X1
prion-like-(Q/N-rich) domain-bearing protein 25, transcript variant X2
prion-like-(Q/N-rich) domain-bearing protein 25
tyramine/octopamine receptor-like, transcript variant X2
tyramine/octopamine receptor-like, transcript variant X1
tyramine/octopamine receptor-like isoform X2
tyramine/octopamine receptor-like isoform X1
tyramine/octopamine receptor-like, transcript variant X3
5-hydroxytryptamine receptor 1D-like isoform X3
neurogenic locus Notch protein, transcript variant X2
neurogenic locus Notch protein, transcript variant X3
neurogenic locus Notch protein, transcript variant X1
neurogenic locus Notch protein isoform X2
neurogenic locus Notch protein isoform X3
neurogenic locus Notch protein isoform X1
putative golgin subfamily A member 6-like protein 3, transcript variant X2
putative golgin subfamily A member 6-like protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
putative golgin subfamily A member 6-like protein 3 isoform X1
putative golgin subfamily A member 6-like protein 3 isoform X2
uncharacterized LOC125063631, transcript variant X2
uncharacterized LOC125063631, transcript variant X1
uncharacterized protein LOC125063631 isoform X1
uncharacterized protein LOC125063631 isoform X2
neuropathy target esterase sws, transcript variant X3
neuropathy target esterase sws, transcript variant X1
neuropathy target esterase sws, transcript variant X4
neuropathy target esterase sws, transcript variant X2
neuropathy target esterase sws, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 84 samples with support for all annotated introns
neuropathy target esterase sws isoform X3
neuropathy target esterase sws isoform X2
neuropathy target esterase sws isoform X1
neuropathy target esterase sws isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
RNA-binding protein 1, transcript variant X2
RNA-binding protein 1, transcript variant X1
RNA-binding protein 1, transcript variant X3
RNA-binding protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00563
UDP-xylose and UDP-N-acetylglucosamine transporter-like
uncharacterized LOC125063396, transcript variant X2
uncharacterized protein LOC125063396 isoform X2
uncharacterized LOC125063396, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
uncharacterized protein LOC125063396 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00049
serine/arginine repetitive matrix protein 1-like, transcript variant X1
serine/arginine repetitive matrix protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 148 samples with support for all annotated introns
histone-lysine N-methyltransferase SMYD3, transcript variant X2
histone-lysine N-methyltransferase SMYD3, transcript variant X1
histone-lysine N-methyltransferase SMYD3
uncharacterized protein C1orf131 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 168 samples with support for all annotated introns
uncharacterized LOC125063377, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 166 samples with support for all annotated introns
uncharacterized LOC125063377, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
uncharacterized protein LOC125063377 isoform X1
uncharacterized protein LOC125063377 isoform X2
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
UPF0605 protein CG18335-like, transcript variant X1
UPF0605 protein CG18335-like, transcript variant X2
kynurenine aminotransferase, transcript variant X2
kynurenine aminotransferase, transcript variant X3
kynurenine aminotransferase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC125063816, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
uncharacterized LOC125063816, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized protein LOC125063816 isoform X1
uncharacterized protein LOC125063816 isoform X2
chymotrypsin-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chymotrypsin-2-like, transcript variant X1
chymotrypsin-2-like, transcript variant X3
uncharacterized LOC125048461, transcript variant X1
uncharacterized LOC125048461, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125063808, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
uncharacterized LOC125063808, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 136 samples with support for all annotated introns
uncharacterized LOC125063808, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 134 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
deoxynucleotidyltransferase terminal-interacting protein 2
estradiol 17-beta-dehydrogenase 8, transcript variant X1
estradiol 17-beta-dehydrogenase 8, transcript variant X2
estradiol 17-beta-dehydrogenase 8 isoform X1
estradiol 17-beta-dehydrogenase 8 isoform X2
mitochondrial cardiolipin hydrolase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
nuclear hormone receptor FTZ-F1 beta, transcript variant X1
nuclear hormone receptor FTZ-F1 beta, transcript variant X3
nuclear hormone receptor FTZ-F1 beta, transcript variant X2
serine/arginine repetitive matrix protein 2, transcript variant X1
serine/arginine repetitive matrix protein 2, transcript variant X3
serine/arginine repetitive matrix protein 2, transcript variant X2
serine/arginine repetitive matrix protein 2 isoform X3
serine/arginine repetitive matrix protein 2 isoform X1
serine/arginine repetitive matrix protein 2 isoform X2
rab GTPase-activating protein 1-like, transcript variant X2
rab GTPase-activating protein 1-like, transcript variant X1
rab GTPase-activating protein 1-like, transcript variant X3
rab GTPase-activating protein 1-like, transcript variant X8
rab GTPase-activating protein 1-like, transcript variant X7
rab GTPase-activating protein 1-like, transcript variant X6
rab GTPase-activating protein 1-like isoform X2
rab GTPase-activating protein 1-like isoform X1
rab GTPase-activating protein 1-like isoform X3
rab GTPase-activating protein 1-like isoform X6
rab GTPase-activating protein 1-like isoform X5
rab GTPase-activating protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
rab GTPase-activating protein 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
rab GTPase-activating protein 1-like isoform X4
stress-activated map kinase-interacting protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
SET and MYND domain-containing protein 4-like
aquaporin AQPAe.a, transcript variant X1
aquaporin AQPAe.a, transcript variant X2
aquaporin AQPAe.a, transcript variant X4
aquaporin AQPAe.a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns